RGMP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Feb 2024 @ 15:32):

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells...

Stats
Today's Volume	600.00
Average Volume	9.00
Market Cap	2 295.00
EPS	$-0.00878 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00400 (67.80%)

Volume Correlation

Long: 0.06 (neutral)

Short: 0.00 (neutral)

Signal:(27.795) Neutral

Regnum Corp. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regnum Corp. Correlation - Currency/Commodity

0.19
( neutral )

0.64
( weak )

0.00
( neutral )

0.36
( neutral )

-0.39
( neutral )

0.57
( weak )

Regnum Corp. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.0340

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.0340

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.0110

FY	2020
Revenue:	$9 000.00
Gross Profit:	$6 772.00 (75.24 %)
EPS:	$-0.00496

Financial Reports:

No articles found.

Regnum Corp.